Gyre Therapeutics, Inc..
GYRE.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Gyre Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of liver diseases. The company's lead product candidate is F351, a small molecule drug in clinical development for the treatment of primary biliary cholangitis...Show More
Better Health for All
0
No evidence available to assess Gyre Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Gyre Therapeutics, Inc. is a biopharmaceutical company focused on drug discovery and development. The provided articles detail its financial performance, clinical trials, regulatory approvals for drug candidates, and corporate governance. There is no evidence that the company offers lending, insurance, or deposit services to consumers, nor does it engage in activities related to financial inclusion, fair lending, or wealth building for underserved populations. Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable to Gyre Therapeutics, Inc. based on the provided information.
Fair Pay & Worker Respect
0
No specific, concrete data points were found across the provided articles to assess Gyre Therapeutics, Inc. against any of the KPIs for Fair Pay & Worker Respect. The articles explicitly state that no relevant data is available for metrics such as living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.
1
Fair Trade & Ethical Sourcing
0
No evidence available to assess Gyre Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
Gyre Therapeutics, Inc. is not in compliance with Nasdaq's audit committee requirements as of June 30, 2024, due to a vacancy on its Audit Committee following a resignation.
1
The company has been granted a cure period to address this issue.
2
Kind to Animals
0
No evidence was found in the provided article to assess Gyre Therapeutics, Inc. against any of the 'Kind to Animals' KPIs.
No War, No Weapons
0
Gyre Therapeutics, Inc. is a biopharmaceutical company focused on liver diseases.
1
The provided articles, including its corporate website, governance principles, terms of use, and code of conduct, do not contain any specific information or data points related to arms manufacturing, military contracts, dual-use technology, sales to embargoed regimes, peacebuilding investments, or any other metrics directly associated with the 'No War, No Weapons' ethical value. The Board of Directors oversees the management of the company's business.
2
but there is no evidence of any defense-related business activities, leading to a score of 0 for 'board_oversight_defense' as it is not applicable to the company's core operations. All other KPIs are omitted due to a lack of relevant evidence.
Planet-Friendly Business
0
No specific, quantifiable evidence was found across the provided articles for any of the Planet-Friendly Business KPIs. The articles contain general statements about the company's commitment to environmental responsibility and compliance with regulations, but lack concrete data points such as emissions figures, renewable energy usage, waste diversion rates, or specific environmental programs and their outcomes. Information regarding 'no material claims, lawsuits, penalties or administrative actions relating to non-compliance with occupational health and safety laws or regulations' does not pertain to environmental compliance violations.
1
Respect for Cultures & Communities
0
No evidence available to assess Gyre Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
Gyre Therapeutics, Inc. holds ISO/IEC 27001:2013, Crown Service Supplier (G-Cloud 14), and Cyber Essentials Plus certifications.
1
The company's privacy policy grants data access, deletion, and correction rights, and an opt-out for sale/sharing for California residents, but these comprehensive controls are explicitly limited to specific jurisdictions.
2
Gyre states it performs vulnerability scanning and risk assessments.
3
The company explicitly mentions compliance with GDPR, CCPA, and UK GDPR.
4
Gyre states that personnel processing data are informed of confidentiality and trained on responsibilities.
5
The company commits to processing data only as necessary and deleting it upon termination or request, but does not specify retention periods.
6
Gyre commits to notifying users of data breaches, but no specific breach incidents are reported.
7
The company states it implements security measures to prevent unauthorized access and disclosure.
8
Gyre states it implements industry-standard technical and organizational security measures, but no specific encryption details are provided.
9
Zero Waste & Sustainable Products
0
No specific evidence was found regarding Gyre Therapeutics, Inc.'s performance or initiatives related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education. The provided articles discuss general trends and challenges within the pharmaceutical industry but do not offer company-specific data for GYRE.US.